Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Greece

Marie Skłodowska-Curie Action · Running

NEUROHEALTH Transitioning Psychotropic Alkaloids From Plants And Mushrooms To Neuroprotective Agents: Incorporating Computational Tools For The Development Of Novel Therapeutics

Coordinator
Ethniko Kai Kapodistriako Panepistimio Athinon, Greece
Runs
1 October 2025 to 30 September 2029
Status
Running
EU funding
€1.8m
Total cost
—
Partners
10 organisations in 7 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101236767

What the project is doing

In the project's own words, from its summary on CORDIS.

The NeuroHEALTH project aims to address the growing challenge of neurodegenerative diseases, such as Alzheimer's and Parkinson's, which affect millions worldwide and impose significant social and economic burdens. The project will harness the potential of neglected natural products (NPs), like alkaloids, from psychotropic plants and mushrooms that till recently had regulatory constrains. The integration of state of the art phytochemical analysis, with advanced computational tools will accelerate the discovery of novel NPs.

In vitro and in vivo testing assays including zebrafish models will evaluate the safety and efficacy to reveal compounds of interest, that can enhance cognitive health and improve quality of life. Bioactive extracts and NPs will be scaled up and formulated in combination with a market analysis, sustainability and intellectual properties assessment will ensure that findings are relevant and applicable. Through strategic secondments and staff exchanges among academic and industry partners, NeuroHEALTH will foster interdisciplinary collaboration, enhancing knowledge transfer and innovation.

Workshops, conferences, and outreach activities will engage diverse stakeholders, including professionals, policymakers, and the general public, promoting awareness of the project's findings and their implications for health care. By bridging the gap between traditional knowledge and modern science, NeuroHEALTH aims to deliver impactful solutions for neurodegenerative diseases, ultimately contributing to healthier aging populations.

This timely initiative not only addresses urgent societal needs but also positions Europe at the forefront of innovative research in natural product-based therapeutics.

Who is involved

OrganisationCityCountryRole
Ethniko Kai Kapodistriako Panepistimio AthinonAthinaGreeceCoordinator
Galen-NSofiaBulgariaParticipant
Edex - Educational Excellence Corporation LimitedNicosiaCyprusParticipant
Novamechanics LimitedNicosiaCyprusParticipant
Ethniko Kentro Erevnas Kai Technologikis AnaptyxisThermi ThessalonikiGreeceParticipant
Nikolaos A. Fikioris Kai Sia Etaireia Periorismenis EfthynisAthensGreeceParticipant
Fundacion Centro De Excelencia En Investigacion De Medicamentos Innovadores En AndaluciaArmilla GranadaSpainParticipant
Universite Paris CiteParisFranceParticipant
Uniwersytet Medyczny W LublinieLublinPolandParticipant
Paralab-Equipamentos Industriais E De Laboratorio S.a.GondomarPortugalParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI